[Functional state of the adrenal cortex in malignant tumors of the ovaries during thio-TEPA treatment].
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000328:Adult; D003687:Dehydroepiandrosterone / Q000652:urine; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D010912:Pituitary-Adrenal Function Tests; D013852:Thiotepa / Q000627:therapeutic use*; D013997:Time Factors
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D003687:Dehydroepiandrosterone; D000324:Adrenocorticotropic Hormone; D013852:Thiotepa
Funktsional'noe sostoianie kory nadpochechnikov u bol'nykh zlokachestvennymi opukholiami iaichnikov pri lechenii tioTEFom.